President Donald Trump is directing the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."

Trump signed the executive order o

"These treatments are currently in the advanced stages of clinical trials to ensure that they're both safe and effective for the American patients," Trump said.